The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

Logitech maintains a Buy rating, driven by strong Asia growth, B2B momentum, and expanding margins. Q3 2026 results highlight the Americas' turnaround, with B2B-led growth de-risking the Western ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

A new statement from the head of Rust developer Facepunch Studios has once again sparked hopes that canceled Amazon MMO New World could have a route to salvation. After jokingly making an offer for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The Rust Naval update is live, and with it comes a plethora of new things to do and places to explore. The main attraction for this update is, of course, player-made boats, but the real hype behind it ...

As the Rust Naval update finally sails into port, you'd be forgiven for assuming developer Facepunch Studios was ready for a break. More than 12 years on from its initial early access launch, the ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...

I love Express Script, they are great! I get my meds cheap and the pharmacist are all helpful. I cannot say that for all customer service people but they do a great job as well. Just like every ...

Express Scripts to change practices tied to high costs FTC to enforce 10-year settlement Deal requires company to work with local pharmacies Sign up here. "Our ...

Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at ...